Covid-19: DCGI approves emergency use of Gilead’s remdesivir

In India, Gilead has given voluntary licence for production of remdesivir to Cipla, Jubilant Life Sciences, Hetero Drugs and Mylan under a royalty-free arrangement till an alternative drug is found

from Livemint - Science https://ift.tt/370McO0